Boehringer Ingelheim GmbH
Overview
Boehringer Ingelheim GmbH is a leading research-driven pharmaceutical company that develops innovative solutions for global health. As a privately-owned company, it focuses on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing.
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Boehringer Ingelheim GmbH is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Boehringer Ingelheim GmbH holds 0 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- ESMOLOL HCLInactive2001-11-30
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Boehringer Ingelheim GmbH in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Boehringer Ingelheim GmbH? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.